Blindsight

Blindsight is Neuralink's experimental sight device, an array of electrodes placed in the brain's visual cortex, which is the part of the brain that processes what we see. Instead of repairing a damaged eye, it sends electrical pulses into the brain that a person sees as small points of light called phosphenes. Because it skips the eye and the optic nerve completely, Elon Musk has said it could help people who have lost both eyes and their optic nerve, and even people who have been blind from birth, as long as the visual cortex is intact. In September 2024 the FDA granted Blindsight a Breakthrough Device Designation, a status that can speed FDA review of devices for serious conditions.

What is Blindsight?

Blindsight creates the experience of sight in the brain rather than in the eye. A video camera films the scene and sends it wirelessly to the implant, which stimulates the visual cortex so a blind person can start to make out shapes and motion. The implant comes from the same platform as the N1, the device behind Neuralink's first product, Telepathy, which lets paralyzed people control computers and phones with thought alone.

Why Blindsight Exists

Every sight treatment on the market today relies on some surviving piece of the eye, whether it is a retina to stimulate or a nerve to carry the signal. For a large group of people, including those who have lost both eyes, that piece is gone, and today's medicine has nothing to offer them. Blindsight is Neuralink's way to reach those people by going around the broken parts and speaking to the brain directly. It stretches the company's brain implant past paralysis and into restoring the senses, and it does that by starting from the basic science, which Elon calls first principles, instead of copying the eye-based approach that cannot solve this problem.

How it Works

Neuralink's current N1 carries 1,024 electrodes on 64 ultra-thin, flexible polymer threads, which a surgical robot called R1 inserts into the cortex. In Blindsight, pulses of electricity across the electrodes create phosphenes, and the arrangement of those dots forms a rough image, much like the dots on a stadium scoreboard form a picture. More electrodes mean more dots, and more dots mean a sharper picture. In September 2026 Neuralink confirmed a 3,000-channel implant in a VOICE participant, about 3 times the channels of earlier devices, and it has said future devices, Blindsight among them, will carry more than 10,000.

Elon has said the first images will be low resolution and should sharpen over time.

The Economics of Blindsight

Blindsight is still in development, so its economics run on Neuralink's funding. The company raised a $650 million Series E in June 2025, more than double its $280 million Series D in 2023.

If Blindsight works, Neuralink would keep an ongoing relationship with each patient and see its cost per point of light fall as electrode counts climb and surgeries become routine.

Current Status of Blindsight

As of October 2026 Blindsight is preparing for its first human implant, and the next milestone is FDA approval for a vision trial. Its trial page invites people to join a patient registry to hear when United States trials open.

Neuralink's other trials build the experience Blindsight will rely on. Neura Pod counts 27+ people with Neuralink implants as of October 2026. First recipient Noland Arbaugh regained control of a computer and returned to college, and Brad, a participant with amyotrophic lateral sclerosis (ALS, a disease that destroys the nerves that control muscle), regained the ability to look around a room using a swivel camera he steers with his thoughts.

What Comes Next

The next steps are FDA approval for a vision trial, the first Blindsight surgeries in people, and the factory capacity to build higher-channel implants. Elon has also raised the idea of sight beyond what humans normally have, including seeing in infrared or ultraviolet light, as a goal for later devices.

The Bottom Line

The first human trial will show how sharp the points of light become, and every jump in electrode count gives Blindsight more dots to draw with.